Skip to main content
Charles Nemeroff, MD, Psychiatry, Austin, TX, Ascension Seton Medical Center Austin

CharlesBNemeroffMDPhD

Psychiatry Austin, TX

Geriatric Psychiatry, Psychopharmacology, Psychosomatic Medicine

Professor and Chair, Department of Psychiatry, University of Texas at Austin, Dell Medical School and Director, Institute for Early Life Adversity Research

Dr. Nemeroff is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nemeroff's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Psychiatry, 1983 - 1985
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Psychiatry, 1981 - 1983
  • University of North Carolina School of Medicine
    University of North Carolina School of MedicineClass of 1981

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2021 - 2021
  • TX State Medical License
    TX State Medical License 2018 - 2022
  • FL State Medical License
    FL State Medical License 2010 - 2023
  • GA State Medical License
    GA State Medical License 1991 - 2022
  • NC State Medical License
    NC State Medical License 1982 - 2022
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Geriatric Psychiatry

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2002
  • Top MD Consumers Checkbook
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Journal Articles

  • Screening for Adverse Childhood Experiences  
    Jeoffry B Gordon, Charles B Nemeroff, JAMA
  • American Psychiatric Association Publishing  
    Alik S Widge, Charles B Nemeroff, Ned H Kalin, Thilo Deckersbach, National Institutes of Health
  • Response Rate Profiles for Major Depressive Disorder: Characterizing Early Response and Longitudinal Nonresponse  
    Charles B Nemeroff, W Edward Craighead, Helen S Mayberg, Boadie W Dunlop, Depression and Anxiety
  • Join now to see all

Lectures

  • The Search for Treatments for Veterans with Major Depression 
    Global Technology Community (GTC), Boston, Massachusetts - 9/9/2013
  • Side Effects: Adherence, Tolerability And Insight In Psychiatric Treatment 
    North Carolina Psychiatric Association, Asheville, North Carolina - 9/19/2013
  • 6th CNS Partnering & Deal-Making Conference 2013 
    Global Technology Community (GTC), Boston, Massachusetts - 9/9/2013
  • Join now to see all

Authored Content

  • F179. Epigenetic Biomarkers in Women with Posttraumatic Stress Disorder After CRF1 Receptor Antagonist TreatmentApril 2018
  • F179. Epigenetic Biomarkers in Women with Posttraumatic Stress Disorder After CRF1 Receptor Antagonist TreatmentApril 2018

Press Mentions

  • Psychopharmacology May Be on Verge of New Era
    Psychopharmacology May Be on Verge of New EraMarch 19th, 2020
  • Dell Medical School Dean Clay Johnston Elected to National Academy of Medicine
    Dell Medical School Dean Clay Johnston Elected to National Academy of MedicineOctober 21st, 2019
  • Ariana Grande Shares Brain Scan and Opens up About PTSD
    Ariana Grande Shares Brain Scan and Opens up About PTSDApril 12th, 2019
  • Join now to see all

Grant Support

  • Prospective Determination of Psychobiological Risk Factors for Post-traumatic Stress DisorderNational Institute of Mental Health2012–Present
  • Early Life Stress In NON Human Primates And HumansNational Center For Research Resources2005–2009
  • Collaborative Mood Disorders InitiativeNational Center For Research Resources2005–2009
  • Clinical PsychobiologyNational Institute Of Mental Health2004–2008
  • Emory Conte Center For The Neuroscience Of Mental DisordersNational Institute Of Mental Health2007
  • Emory Conte Center For The Neuroscience Of Mental Disorders Clinical PsychobiolNational Center For Research Resources2007
  • Special Scientific Procedures: Statistical Modeling CoreNational Institute Of Mental Health2006–2007
  • Secondary Research Project: Monoamine Transporter OccupancyNational Institute Of Mental Health2006–2007
  • Secondary Research Project: GeneticsNational Institute Of Mental Health2006–2007
  • Research Methods CoreNational Institute Of Mental Health2006–2007
  • Primary Research Project: Functional MRINational Institute Of Mental Health2006–2007
  • Predictors Of Antidepressant Treatment RESPONSE: The Emory CidarNational Institute Of Mental Health2006–2007
  • Operations, Clinical Assessments And Adminstrative CoreNational Institute Of Mental Health2006–2007
  • Neurotensin An Endogenous Neuroleptic-Like PeptideNational Institute Of Mental Health2006–2007
  • Psychobiology Of Early-Life TraumaNational Center For Research Resources2006
  • Emory-Gsk-Nimh Collaborative Mood Disorders InitiativeNational Institute Of Mental Health2003–2006
  • Emory Conte Center For Neuroscience Of Mental DisordersNational Institute Of Mental Health1999–2006
  • Early Adverse Life Events And Major DepressionNational Center For Research Resources1998–2006
  • Emory Conte Center For The Neuroscience Of Mental DisordersNational Center For Research Resources2005
  • Does Fluoxetine Reverse The Effects Of Early Life Stress On The CNS CRF SystemNational Center For Research Resources2004
  • Neurotensin, An Endogenous Neuroleptic-Like PeptideNational Institute Of Mental Health1995–2004
  • Psychobiology Of Corticotropin-Releasing FactorNational Institute Of Mental Health1991–2004
  • Fluoxetine In Child Abuse--Psychological/Endocrine DISNational Center For Research Resources2001–2002
  • HPA Axis Studies In Women Abused As ChildrenNational Institute Of Mental Health1999–2002
  • Paroxetine--Treatment Of Exaggerated Platelet Reactivity With Major DepressionNational Center For Research Resources1999–2002
  • Exaggerated Platelet Reactivity In Major DepressionNational Center For Research Resources1998–2002
  • Neurotensin--An Endogenous Neuroleptic LIKE PeptideNational Institute Of Mental Health1996–1999
  • Depression As A Risk Factor For Ischemic Heart DiseaseNational Center For Research Resources1996–1999
  • Core--Biological Tissues And FluidsNational Institute Of Mental Health1997–1998
  • Neuropeptide/Cholinergic Function/Alzheimers DiseaseNational Institute Of Mental Health1996–1998
  • Infrastructure Support ProgramNational Institute Of Mental Health1994–1998
  • Neurochemical Pathology Of Human Cocaine AbuseNational Institute On Drug Abuse1995
  • Neurotensin, An Endogenous Neuroleptic-Like PeptideNational Institute Of Mental Health1992–1994
  • Neuropeptide/Cholinergic Function/Alzheimer'S DiseaseNational Institute Of Mental Health1992–1993
  • Pancreatic Cancer, Depression And Immune FunctionNational Institute Of Mental Health1991–1993
  • Neurotensin, An Endogenous Neuroleptic-Like PeptideNational Institute Of Mental Health1987–1991
  • Neuropeptide/Cholinergic Function/Alzheimer'S DiseaseNational Institute Of Mental Health1985–1991
  • Psychobiology Of Corticotropin-Releasing FactorNational Institute Of Mental Health1989–1990
  • The Psychobiology Of Corticotropin-Releasing FactorNational Institute Of Mental Health1987–1988
  • Neurotensin--An Endogenous Neuroleptic-Like PeptideNational Institute Of Mental Health1985–1986

Hospital Affiliations